Inter-rater Agreement for Movement Disorder Classification in Children with Hyperkinetic Movement Disorders.

IF 2.6 4区医学 Q2 CLINICAL NEUROLOGY

Movement Disorders Clinical Practice Pub Date : 2024-10-26 DOI:10.1002/mdc3.14252

Sanem Yilmaz, Jennifer Vermilion, Shannon Dean, Roxanna Pourdeyhimi, Jonathan W Mink

{"title":"Inter-rater Agreement for Movement Disorder Classification in Children with Hyperkinetic Movement Disorders.","authors":"Sanem Yilmaz, Jennifer Vermilion, Shannon Dean, Roxanna Pourdeyhimi, Jonathan W Mink","doi":"10.1002/mdc3.14252","DOIUrl":null,"url":null,"abstract":"Background: Accurate classification is essential for addressing childhood movement disorders (MD), but the common coexistence of multiple MDs complicates this process.Objective: The aim was to assess inter-rater agreement on classifying hyperkinetic MDs among pediatric neurologists with expertise in MDs.Methods: Five pediatric neurologists were requested to examine 112 videos of 66 pediatric patients. Based on the Movement Disorder-Childhood Rating Scale, 3 queries were posed: (Q1) Is there more than 1 MD? (Q2) What is the (predominant) MD? (Q3) What is the other MD (if present)?Results: The final agreement rates were 57.5% for Q1, 66.6% for Q2, and 43.9% for absolute agreement. All videos with absolute agreement at the first evaluation featured 1 MD, whereas only 2 videos with multiple MDs could totally agree in the final review.Conclusions: This study reveals significant discordance in classification even among pediatric neurologists with expertise in MDs and highlights the necessity for a standardized approach.","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Movement Disorders Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/mdc3.14252","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Accurate classification is essential for addressing childhood movement disorders (MD), but the common coexistence of multiple MDs complicates this process.

Objective: The aim was to assess inter-rater agreement on classifying hyperkinetic MDs among pediatric neurologists with expertise in MDs.

Methods: Five pediatric neurologists were requested to examine 112 videos of 66 pediatric patients. Based on the Movement Disorder-Childhood Rating Scale, 3 queries were posed: (Q1) Is there more than 1 MD? (Q2) What is the (predominant) MD? (Q3) What is the other MD (if present)?

Results: The final agreement rates were 57.5% for Q1, 66.6% for Q2, and 43.9% for absolute agreement. All videos with absolute agreement at the first evaluation featured 1 MD, whereas only 2 videos with multiple MDs could totally agree in the final review.

Conclusions: This study reveals significant discordance in classification even among pediatric neurologists with expertise in MDs and highlights the necessity for a standardized approach.

查看原文本刊更多论文

运动功能亢进症儿童运动障碍分类的评分者之间的一致性。

背景：准确的分类对于处理儿童运动障碍（MD）至关重要，但多种运动障碍并存的普遍现象使这一过程变得复杂：方法：要求五名儿科神经学家检查 66 名儿科患者的 112 个视频：方法：要求五名儿科神经学家检查 66 名儿科患者的 112 个视频。根据运动障碍-儿童分级量表，提出了 3 个问题：（Q1）是否存在不止一种运动障碍？(Q2）主要的运动障碍是什么？(Q3) 其他运动障碍（如果存在）是什么？Q1 的最终一致率为 57.5%，Q2 为 66.6%，绝对一致率为 43.9%。所有在首次评估中绝对一致的视频都有 1 个 MD，而只有 2 个有多个 MD 的视频在最终审查中完全一致：这项研究表明，即使是精通 MD 的儿科神经学家在分类方面也存在很大的不一致，因此强调了采用标准化方法的必要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Movement Disorders Clinical Practice CLINICAL NEUROLOGY-

CiteScore

4.00

自引率

7.50%

发文量

218

期刊介绍： Movement Disorders Clinical Practice- is an online-only journal committed to publishing high quality peer reviewed articles related to clinical aspects of movement disorders which broadly include phenomenology (interesting case/case series/rarities), investigative (for e.g- genetics, imaging), translational (phenotype-genotype or other) and treatment aspects (clinical guidelines, diagnostic and treatment algorithms)